6 doctors weighed in:

What is a lymphocyte cd20? Is it a type of cancer marker?

6 doctors weighed in
Dr. Ed Friedlander
Pathology
3 doctors agree

In brief: Yes

Most of your normal b-cells bear this marker. It's typically used in subclassifying malignant lymphomas that have already been diagnosed, in combination with a huge array of other markers, though it can be used to "light up" the distribution of b-cells in non-cancerous tissue as well.
It's the target for Rituximab and some other new rx's.

In brief: Yes

Most of your normal b-cells bear this marker. It's typically used in subclassifying malignant lymphomas that have already been diagnosed, in combination with a huge array of other markers, though it can be used to "light up" the distribution of b-cells in non-cancerous tissue as well.
It's the target for Rituximab and some other new rx's.
Dr. Ed Friedlander
Dr. Ed Friedlander
Thank
Dr. Andrew Turrisi
Radiation Oncology
2 doctors agree

In brief: It is a major

B-lymphocyte marker, carried by benign cells as well as malgnant cells with b-cell lineage (as opposed to t-cell lineage).
The ab Rituximab has been generated against it and is a key component in treating b-cell lymphomas.

In brief: It is a major

B-lymphocyte marker, carried by benign cells as well as malgnant cells with b-cell lineage (as opposed to t-cell lineage).
The ab Rituximab has been generated against it and is a key component in treating b-cell lymphomas.
Dr. Andrew Turrisi
Dr. Andrew Turrisi
Thank
Read more answers from doctors